Dr. Mark Fishman of the Novartis Institutes for Biomedical Research, discusses several current programs in drug discovery that promise to change the practice of medicine. Each grew from basic science
Statement of Lawrence Goldstein, Ph.D. Distinguished Professor, Dept. of Cellular and Molecular Medicine, Dept. of Neurosciences Director, UC San Diego Stem Cell Program Scientific Director, Sanford Consortium for Regenerative Medicine
One of the features of many cancers is the loss of genome integrity. One of the most stunning examples of this is chromothripsis. Chromothripsis involves the shuffling or rearrangement of
One of the features of many cancers is the loss of genome integrity. One of the most stunning examples of this is chromothripsis. Chromothripsis involves the shuffling or rearrangement of
Scientific dogma for decades has dictated that once a cell dies it cannot be resurrected. Dr. Denise Montell discusses her groundbreaking discovery that overturns this widely held belief. What she
Dr. Keith R. Yamamoto, Vice Chancellor for Research, UCSF Executive Vice Dean, School of Medicine Professor, Cellular & Molecular Pharmacology July 14, 2015 Testimony for the Record for the Subcommittee
"Unlocking the Cures for America’s Most Deadly Diseases”
The Coalition for the Life Sciences (CLS) would like to thank the Senate Labor, Health and Human Services, and Education and Related Agencies (Labor-HHS) Appropriations Subcommittee for its commitment to
6120 Executive Blvd.,
Suite 750
Rockville, MD 20852
T 301 347.9309
F 301 347.9310
